Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
GSK vs CSL: Revenue Comparison
GSK (GSK) and CSL (CSL.AX) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $7.3B for CSL. GSK leads on revenue.
GSK's gross margin is 73.0% versus 44.4% for CSL. GSK's net margin is 5.2% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, CSL.| Metric | GSK | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $7.30B |
| Cost of Revenue | $2.85B | $4.06B |
| Gross Profit | $7.74B | $3.24B |
| Operating Income | $606.00M | $1.39B |
| Net Income | $548.00M | $-2.94B |
| R&D Expense | $4.37B | $614.00M |
| Earnings Per Share | $0.28 | -$6.14 |
| Gross Margin | 73.0% | 44.4% |
| Operating Margin | 5.7% | 19.0% |
| Net Profit Margin | 5.2% | -40.2% |
| Free Cash Flow | $2.78B | $1.76B |
| Cumulative Free Cash Flow | $157.21B | $21.56B |
| Operating Cash Flow | $3.19B | $2.09B |
| Cash & Equivalents | $3.89B | $1.51B |